Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 174   

Articles published

BMY 55.80 -0.15 (-0.27%)
price chart
Insider Trading Activity Bristol-Myers Squibb Co (NYSE:BMY) – Director Sold ...
On 8/10/2012 James M Cornelius, Director, sold 10,000 with an average share price of $31.81 per share and the total transaction amounting to $318,100.00.
Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine's ...
BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Foundation Medicine (NASDAQ:FMI) today announced a collaboration that leverages Foundation Medicine's comprehensive genomic profiling and molecular information solutions to ...
Orbimed Advisors LLC Decreases Stake in Bristol-Myers Squibb Co (BMY)  Sports Perspectives
Stock Jumping Abnormally High: Bristol-Myers Squibb Company (BMY)  HugoPress
Dodge & Cox Buys Bristol-Myers Squibb Company, Zayo Group Holdings, Medtronic ...
Dodge & Cox initiated holdings in Zayo Group Holdings Inc. Their purchase prices were between $29.81 and $35.14, with an estimated average price of $32.74.
Bristol-Myers Squibb Names New R&D Chief
Bristol-Myers Squibb Co. said it would replace its research-and-development chief, naming a Massachusetts General Hospital executive to the key job as the company seeks to move past a major drug-development setback.
Forget the Distractions: Bristol-Myers Squibb Is a Bargain  Motley Fool
Bristol-Myers Squibb to Announce Results for First Quarter 2017 on April 27  Yahoo Finance
CytomX Therapeutics shoots higher as it's set for US$200mln upfront payment ...
CytomX Therapeutics Inc (NASDAQ:CTMX) saw its shares shoot almost 25% higher in early New York trading after the biotech firm said it would receive a US$200mln upfront payment from drugs giant Bristol-Myers Squibb Co. (NYSE:BMY). The payment is ...
Bristol-Myers Squibb and CytomX Therapeutics Extend Deal  Yahoo Finance
Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol ...  Benzinga
Bristol-Myers Squibb's Valuation Compared to Its Peers'
Headquartered in New York City, Bristol-Myers Squibb (BMY) is an American pharmaceutical company dealing in innovative medicines for patients with serious diseases in therapeutic areas such as virology, oncology, cardiovascular, neuroscience, and ...
Analyst's Predictions on Bristol-Myers Squibb Company (BMY), The Kroger ...  StockNewsJournal
Average Brokerage Rating Of Bristol-Myers Squibb Company (BMY), Oracle ...  The USA Commerce
Bristol-Myers Squibb Company (BMY) Is Trying To Tell Investors Something ...
The technicals for Bristol-Myers Squibb Company (BMY) has spoken via its technical chart and the message is loud and clear.
BRISTOL-MYERS SQUIBB COMPANY (OTCMKTS:BMYMP) Files An 8-K Departure of ...
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Bristol-Myers Squibb (BMY) CEO Giovanni Caforio Presents at Cowen and Company ...
Good afternoon, I'd like to welcome Bristol-Myers Squibb to the Cowen Conference representing the company is Giovanni Caforio, who is the Chief Executive Officer, also here from the company is John Elicker, In-charge of Investor Relations. Before I ...
Insider Trading Activity Bristol-Myers Squibb Co (NYSE:BMY) – EVP Sold 92405 ...  Market Exclusive
Carl Icahn Takes Aim at Bristol-Myers Squibb
In today's episode of the Motley Fool's Industry Focus: Healthcare, the team discusses what Icahn may have in mind for Bristol-Myers Squibb and if an outright sale of the company could be in the cards. Also, the team dives into Celgene Corp.
Owning Bristol-Myers Squibb With Less Risk  Seeking Alpha
Insider Trading Activity Bristol-Myers Squibb Co (NYSE:BMY) – Director ...  Market Exclusive